Clinical Trial

Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis

Study acronym: EYETAC
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The primary objective of the study is to investigate the safety and tolerability of NOV05 eye drops at two concentrations QID in patients with active non-infectious anterior uveitis.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-12-09; most recent amendment 2026-06-12.
Status change: Not Yet Recruiting → Recruiting 2026-03-30
Trial Details
NCT Number NCT07285070
Lead Sponsor Novaliq GmbH
Conditions Non-infectious Anterior Uveitis
Enrollment 20 participants
Start Date 2026-03-16
Primary Completion 2026-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-07-28